GNTA
Genenta Science S.p.A.
NASDAQ · Healthcare · Biotechnology · IT
$0.96
+1.01%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$0.26
- Revenue estimate
- —
Latest reported
- Last report date
- Oct 10, 2025
- EPS actual
- -$0.24
- EPS estimate
- -$0.45
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +46.4%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027